Market Research Logo

Digital Dose Inhalers Market by Product and Geography - Global Forecast and Analysis 2019-2023

Global Digital Dose Inhalers Market: About this market

Technavio’s digital dose inhalers market analysis considers sales from both metered-dose and soft mist inhalers and dry powder inhalers . Our analysis also considers the sales of digital dose inhalers in Asia. Europe, North America, and ROW. In 2018, the metered dose and soft mist inhalers segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as delivery of accurate dose during inhalation, cost-effectiveness will play a significant role in the metered-dose and soft mist inhalers segment to maintain its market position. Also, our global digital dose inhalers market report looks at factors such as increasing prevalence of chronic respiratory diseases, increasing product launches by prominent players, and technological advances. However, high costs associated with digital dose inhalers, lack of awareness and interoperability, and limited availability of digital dose inhalers and digital security issues may hamper the growth of the digital dose inhalers industry over the forecast period.

Global Digital Dose Inhalers Market: Overview

Technological advancements

Digital dose inhalers or smart inhalers are an advanced type of inhalers, which help to achieve an effective outcome for COPD and asthma. Pharmaceutical companies are developing smart mist inhalers that optimize and improve drug delivery in patients with COPD. Market vendors are increasingly integrating Bluetooth technology and digitalizing inhaler devices to minimize common errors by measuring patient inhalation, increase the drug delivery efficacy, reduce health care costs, improve medication adherence, and enhance patient outcome. Such benefits of technological advancements will lead to the expansion of the global digital dose inhalers market at a CAGR of almost 13% during the forecast period.

Rising integration of AI and the adoption of IoT

Digitalization has opened the doors for healthcare professionals to improve the treatment of asthma and COPD. AI technology uses algorithms and software to analyze complex medical data and minimizes the need for direct human input. Moreover, IoT based digital inhalers help customers to monitor their condition, understand the measurement of dosage, and prevent subsequent respiratory attacks. The sensors integrated digital dose inhaler systems help in minimizing emergency visits reducing risks and enhances patient outcome. This rise in the integration of AI and IoT is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global digital dose inhalers market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global digital dose inhalers market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital dose inhalers manufacturers, that include AstraZeneca Plc, GlaxoSmithKline Plc, Novartis AG, OPKO Health Inc., Teva Pharmaceutical Industries Ltd.

Also, the digital dose inhalers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
Metered dose and soft mist inhalers - Market size and forecast 2018-2023
Dry powder inhalers - Market size and forecast 2018-2023
Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Rising integration of AI and adoption of IoT
Business strategies
Growing internet connectivity and use of smartphone devices
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
AstraZeneca Plc
GlaxoSmithKline Plc
Novartis AG
OPKO Health Inc.
Teva Pharmaceutical Industries Ltd.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Hospital admission rate for asthma and COPD in adults in 2015 per 100,000 population
Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2018
Exhibit 19: Product - Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Metered dose and soft mist inhalers - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Metered dose and soft mist inhalers - Year-over-year growth 2019-2023 (%)
Exhibit 23: Dry powder inhalers - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Dry powder inhalers - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Percentage of population with self-reported COPD aged 15 and over in 2014 (Europe)
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: AstraZeneca Plc - Vendor overview
Exhibit 47: AstraZeneca Plc - Product segments
Exhibit 48: AstraZeneca Plc - Organizational developments
Exhibit 49: AstraZeneca Plc - Geographic focus
Exhibit 50: AstraZeneca Plc - Segment focus
Exhibit 51: AstraZeneca Plc - Key offerings
Exhibit 52: AstraZeneca Plc - Key customers
Exhibit 53: GlaxoSmithKline Plc - Vendor overview
Exhibit 54: GlaxoSmithKline Plc - Business segments
Exhibit 55: GlaxoSmithKline Plc - Organizational developments
Exhibit 56: GlaxoSmithKline Plc - Geographic focus
Exhibit 57: GlaxoSmithKline Plc - Segment focus
Exhibit 58: GlaxoSmithKline Plc - Key offerings
Exhibit 59: GlaxoSmithKline Plc - Key customers
Exhibit 60: Novartis AG - Vendor overview
Exhibit 61: Novartis AG - Business segments
Exhibit 62: Novartis AG - Organizational developments
Exhibit 63: Novartis AG - Geographic focus
Exhibit 64: Novartis AG - Segment focus
Exhibit 65: Novartis AG - Key offerings
Exhibit 66: Novartis AG - Key customers
Exhibit 67: OPKO Health Inc. - Vendor overview
Exhibit 68: OPKO Health Inc. - Business segments
Exhibit 69: OPKO Health Inc. - Organizational developments
Exhibit 70: OPKO Health Inc. - Geographic focus
Exhibit 71: OPKO Health Inc. - Key offerings
Exhibit 72: OPKO Health Inc. - Key customers
Exhibit 73: Teva Pharmaceutical Industries Ltd. - Vendor overview
Exhibit 74: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 75: Teva Pharmaceutical Industries Ltd. - Organizational developments
Exhibit 76: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 77: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 78: Teva Pharmaceutical Industries Ltd. - Key customers
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: Definition of market positioning of vendors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report